HK1025129A1 - Disassociation of interacting molecules. - Google Patents

Disassociation of interacting molecules.

Info

Publication number
HK1025129A1
HK1025129A1 HK00104385A HK00104385A HK1025129A1 HK 1025129 A1 HK1025129 A1 HK 1025129A1 HK 00104385 A HK00104385 A HK 00104385A HK 00104385 A HK00104385 A HK 00104385A HK 1025129 A1 HK1025129 A1 HK 1025129A1
Authority
HK
Hong Kong
Prior art keywords
disassociation
interacting molecules
molecules
interacting
capso
Prior art date
Application number
HK00104385A
Other languages
English (en)
Inventor
David Nicholas Miller-Jones
Karin Bergmann
Susan Louise Watson
Original Assignee
Affymetrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymetrix Inc filed Critical Affymetrix Inc
Publication of HK1025129A1 publication Critical patent/HK1025129A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
HK00104385A 1997-04-02 2000-07-18 Disassociation of interacting molecules. HK1025129A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9706654.2A GB9706654D0 (en) 1997-04-02 1997-04-02 Disassociation of interacting molecules
PCT/GB1998/000975 WO1998044100A1 (en) 1997-04-02 1998-04-02 Disassociation of interacting molecules

Publications (1)

Publication Number Publication Date
HK1025129A1 true HK1025129A1 (en) 2000-11-03

Family

ID=10810141

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104385A HK1025129A1 (en) 1997-04-02 2000-07-18 Disassociation of interacting molecules.

Country Status (10)

Country Link
US (1) US6333157B1 (xx)
EP (1) EP0973885B1 (xx)
JP (1) JP4004548B2 (xx)
KR (1) KR100510606B1 (xx)
AT (1) ATE281517T1 (xx)
CA (1) CA2286302A1 (xx)
DE (1) DE69827375T2 (xx)
GB (1) GB9706654D0 (xx)
HK (1) HK1025129A1 (xx)
WO (1) WO1998044100A1 (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3751979B2 (ja) * 1995-08-25 2006-03-08 アフィメトリックス，インコーポレイテッド 細胞内物質の放出
US20020012916A1 (en) * 1998-10-14 2002-01-31 Gundling Gerard J A method of reducing contamination in an essay vessel
WO2004018081A1 (ja) * 2002-08-21 2004-03-04 Tokyo University Of Agriculture And Technology Tlo Co., Ltd. 電解切断性アフィニティー担体を用いる生体物質の精製法、電解切断性アフィニティー担体、生体物質精製用キット、電解切断性リンカー
US20050069926A1 (en) * 2003-08-01 2005-03-31 Affymetrix, Inc. Helicase-amplified reverse transcription
WO2005038459A2 (en) * 2003-08-06 2005-04-28 Bridger Technologies, Inc. Bridged element for detection of a target substance
AP2773A (en) * 2004-05-13 2013-09-30 Nanobiosym Inc NANO-PCR: Methods and devices for nucleic acid amplification and detection
US7635594B2 (en) 2005-05-09 2009-12-22 Theranos, Inc. Point-of-care fluidic systems and uses thereof
US11287421B2 (en) 2006-03-24 2022-03-29 Labrador Diagnostics Llc Systems and methods of sample processing and fluid control in a fluidic system
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
WO2007124105A2 (en) * 2006-04-21 2007-11-01 Nanobiosym, Inc. Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
EP2484781B1 (en) * 2006-08-01 2017-08-23 Applied Biosystems, LLC Detection of analytes and nucleic acids
CA2934220C (en) 2007-10-02 2019-11-05 Theranos, Inc. Modular point-of-care devices and uses thereof
AR085087A1 (es) 2011-01-21 2013-09-11 Theranos Inc Sistemas y metodos para maximizar el uso de muestras
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
JP2014530358A (ja) 2011-09-25 2014-11-17 セラノス， インコーポレイテッド 多重分析のためのシステム及び方法
US20140364322A1 (en) * 2011-12-28 2014-12-11 Mark A. Hayden Isothermal amplification systems and methods
AU2013315800A1 (en) 2012-09-11 2015-03-12 Theranos Ip Company, Llc Information management systems and methods using a biological signature
AU2014216060A1 (en) 2013-02-18 2015-08-20 Theranos Ip Company, Llc Systems and methods for collecting and transmitting assay results
US9255290B2 (en) * 2013-03-14 2016-02-09 The Regents Of The University Of California Methods and devices for non-therman polymerase chain reaction
US10933417B2 (en) 2013-03-15 2021-03-02 Nanobiosym, Inc. Systems and methods for mobile device analysis of nucleic acids and proteins
ES2707744T3 (es) 2013-12-11 2019-04-04 Accuragen Holdings Ltd Métodos para detectar variantes de secuencia raras
US11286519B2 (en) 2013-12-11 2022-03-29 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
US11859246B2 (en) 2013-12-11 2024-01-02 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
WO2016168755A1 (en) 2015-04-17 2016-10-20 Distributed Bio, Inc. Method for mass humanization of non-human antibodies
KR20180055905A (ko) 2015-10-09 2018-05-25 아큐라젠 홀딩스 리미티드 증폭 산물의 농축을 위한 방법 및 조성물
EP3383994A4 (en) 2015-12-03 2019-08-28 Accuragen Holdings Limited METHODS AND COMPOSITIONS FOR FORMING LIGATURE PRODUCTS
CN109511265B (zh) 2016-05-16 2023-07-14 安可济控股有限公司 通过链鉴定改进测序的方法
SG10202111825YA (en) 2016-08-15 2021-12-30 Accuragen Holdings Ltd Compositions and methods for detecting rare sequence variants
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665216A (en) 1986-10-21 1997-09-09 Northeastern University Capillary column for high performance electrophoretic separation and detection of SDS proteins and system and using the same
AU8517391A (en) * 1990-09-12 1992-03-30 Scientific Generics Limited Electrochemical denaturation of double-stranded nucleic acid
GB9201481D0 (en) 1992-01-23 1992-03-11 Scient Generics Ltd Treatment of nucleic acid material
US5213669A (en) 1992-01-31 1993-05-25 Beckman Instruments, Inc. Capillary column containing a dynamically cross-linked composition and method of use
EP0750680B1 (en) * 1994-03-15 1999-01-13 Scientific Generics Ltd Electrochemical denaturation of double-stranded nucleic acid
US5935825A (en) * 1994-11-18 1999-08-10 Shimadzu Corporation Process and reagent for amplifying nucleic acid sequences
CA2230375A1 (en) * 1995-08-25 1997-03-06 Scientific Generics Limited Release of intracellular material
GB9613980D0 (en) 1996-07-02 1996-09-04 Scient Generics Ltd Denaturation of double-stranded nucleic acid
GB9614544D0 (en) * 1996-07-11 1996-09-04 Scient Generics Ltd Denaturation of double-stranded nucleic acid

Also Published As

Publication number Publication date
DE69827375T2 (de) 2005-10-20
US6333157B1 (en) 2001-12-25
GB9706654D0 (en) 1997-05-21
CA2286302A1 (en) 1998-10-08
JP4004548B2 (ja) 2007-11-07
KR100510606B1 (ko) 2005-08-31
EP0973885B1 (en) 2004-11-03
EP0973885A1 (en) 2000-01-26
DE69827375D1 (de) 2004-12-09
JP2001519658A (ja) 2001-10-23
ATE281517T1 (de) 2004-11-15
WO1998044100A1 (en) 1998-10-08
KR20010005904A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
HK1025129A1 (en) Disassociation of interacting molecules.
PL338001A1 (en) Integrin-bonding peptides and their application
DE69533923D1 (de) Cytokinin-designiertes lerk-5
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
WO2001040307A8 (de) Antikörper gegen signal-regulator-proteine
AU1399495A (en) Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
DK0710228T3 (da) Hydraziner med N3S-konfiguration som radionuclidchelatorer
DE69810535D1 (de) Verdicken von Lösungsmitteln mit elastomeren Siliconpolyethern
AU1957097A (en) Protein separations by capillary electrophoresis using amino acid-containing buffers
IL139478A0 (en) Hybrid protein
DE69434384D1 (de) Metalkomplexbildner
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
DE69328928T2 (de) Varianten in den leltin domäne von selektin
PT759942E (pt) Receptor de interleucina-15
ATE257857T1 (de) Hyaluronan rezeptor (rezeptor durch hyaluronan verurzachte bewelichkeit) und hyaluronan bindende peptide
HUP0100668A2 (hu) Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
DE69634077D1 (de) Haemophilus adhäsionsproteinen
DE69612509T2 (de) Spezifische bindungspartner fuer menschliches karzinoembryonisches antigen, substanzen und methoden
FI970428A (fi) Soluja, joissa on CD4-houkutusreseptoreita ja vastaavia molekyylejä ja menetelmiä
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
WO2000018803A3 (en) Antibodies to mammalian langerhans cell antigen and their uses
GB0024351D0 (en) Dye-labelled peptide and method
DK193486A (da) Pantethinkomponent til haarpermanentboelgning
KR960033677U (ko) 펫트병·캔 겸용 압축 전처리 장치

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130402